These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 32561464)

  • 1. Use of low-molecular-weight heparin in COVID-19 patients.
    Kow CS; Hasan SS
    J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):900-901. PubMed ID: 32561464
    [No Abstract]   [Full Text] [Related]  

  • 2. Fish oil and COVID-19 thromboses.
    Merritt RJ; Bhardwaj V; Jami MM
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1120. PubMed ID: 32682081
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
    Cattaneo M; Bertinato EM; Birocchi S; Brizio C; Malavolta D; Manzoni M; Muscarella G; Orlandi M
    Thromb Haemost; 2020 Aug; 120(8):1230-1232. PubMed ID: 32349132
    [No Abstract]   [Full Text] [Related]  

  • 4. Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanations.
    Marone EM; Rinaldi LF
    J Vasc Surg Venous Lymphat Disord; 2020 Jul; 8(4):694-695. PubMed ID: 32305586
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
    Ferrandis R; Llau JV; Quintana M; Sierra P; Hidalgo F; Cassinello C; Gómez-Luque A
    Crit Care; 2020 Jun; 24(1):332. PubMed ID: 32527286
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 and thrombotic complications: Pulmonary thrombosis rather than embolism?
    Gabrielli M; Lamendola P; Esperide A; Valletta F; Franceschi F
    Thromb Res; 2020 Sep; 193():98. PubMed ID: 32534328
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk Benefit Analysis in Reference to use of LMWH in COVID-19.
    Samajdar SS; Sam PA; Moitra S; Ray Y; Pal J; Joshi SR; Tripathi SK
    J Assoc Physicians India; 2020 Sep; 68(9):52-61. PubMed ID: 32798346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applicability of bedside ultrasonography for the diagnosis of deep venous thrombosis in patients with COVID-19 and treatment with low molecular weight heparin.
    Zhang P; Qu Y; Tu J; Cao W; Hai N; Li S; Qu P; Lv C; Guo R
    J Clin Ultrasound; 2020 Nov; 48(9):522-526. PubMed ID: 32757278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation abnormalities and thrombosis in patients with COVID-19.
    Levi M; Thachil J; Iba T; Levy JH
    Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
    [No Abstract]   [Full Text] [Related]  

  • 10. Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm.
    Spyropoulos AC; Weitz JI
    Circulation; 2020 Jul; 142(2):129-132. PubMed ID: 32658609
    [No Abstract]   [Full Text] [Related]  

  • 11. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.
    Kumar P; Mediwake R; Rhead C
    Br J Hosp Med (Lond); 2020 May; 81(5):1-2. PubMed ID: 32468942
    [No Abstract]   [Full Text] [Related]  

  • 12. [COVID-19 And Urgent Surgeries: What Has Changed?].
    Ribeiro J; Nave P; Paulino A; Ormonde L
    Acta Med Port; 2020 Jul; 33(7-8):532. PubMed ID: 32427097
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential underlying mechanisms of cerebral venous thrombosis associated with COVID-19.
    Speeckaert MM; Speeckaert R; Delanghe JR
    J Neuroradiol; 2020 Nov; 47(6):473-474. PubMed ID: 32620231
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.
    Dragonetti D; Guarini G; Pizzuti M
    Blood Transfus; 2020 Jul; 18(4):328. PubMed ID: 32697931
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease.
    Lozano R; Franco ME
    Med Clin (Barc); 2020 Nov; 155(9):409-410. PubMed ID: 32883507
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter to the Editor about the Article "Excess Mortality Estimation During the COVID-19 Pandemic: Preliminary Data from Portugal https://doi.org/10.20344/amp.13928".
    Knight A
    Acta Med Port; 2020 Jun; 33(6):446-447. PubMed ID: 32378507
    [No Abstract]   [Full Text] [Related]  

  • 17. [Increased risk of deep vein thrombosis in intensive care unit patients with CoViD-19 infections?-Preliminary data].
    Zerwes S; Hernandez Cancino F; Liebetrau D; Gosslau Y; Warm T; Märkl B; Hyhlik-Dürr A
    Chirurg; 2020 Jul; 91(7):588-594. PubMed ID: 32504106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.
    Schulman S
    Semin Thromb Hemost; 2020 Oct; 46(7):772-776. PubMed ID: 32392613
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID-19 Outcomes.
    Nassim D; Jfri A; Litvinov IV; Netchiporouk E
    J Cutan Med Surg; 2020; 24(4):420-421. PubMed ID: 32449619
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to a Comment about the Article Published in Acta Med Port 2020; Apr 27; doi:10.20344/amp.13928.
    Nogueira PJ; De Araújo Nobre M; Nicola PJ; Furtado C; Vaz Carneiro A
    Acta Med Port; 2020 Jul; 33(7-8):534-535. PubMed ID: 32519664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.